Agilent Advanced Therapeutics505BIOVECTRA is a global biotech and pharmaceutical CDMO that specializes in clinical-to-commercial scale production capabilities for biologics, small molecules, fermented small molecules, bioreagents, pDNA, mRNA and LNP manufacturing, and fill/finish. Flexibility, creativity, process optimization, and compliance are at the heart of our method. With more than 50 years of experience, over 640 employees, and cGMP facilities in Prince Edward Island and Nova Scotia, Canada we assure our programs advance on time and with the highest quality outcomes. Learn more about BIOVECTRA today!
